Skip to main content
. 2021 Oct 14;24:100851. doi: 10.1016/j.conctc.2021.100851

Table 3.

Reasons for study drug discontinuation.

Reason Drug Discontinuation Fluconazole (N = 33) Placebo (N = 39) All Subjects (N = 72)
Lost to Follow-up (%) 10 (30) 7 (18) 17 (24)
Voluntary Withdrawal by Subject (%)
Unable to Return for Follow-up 0 4 (10) 4 (6)
Moved Away for Work 2 (6) 0 2 (3)
Decrease in Sleep 0 2 (5) 2 (3)
Worried about Long-Term Side Effects 0 2 (5) 2 (3)
Withdrawal by Investigator (%)
Unblinded for Treatment for Coccidioidomycosis 0 2 (5) 2 (3)
Patient-Reported Syncopal Event 2 (6) 0 2 (3)
Health-Related Event (%)
Atrial Fibrillation 0 2 (5) 3 (4)
Pruritis 1 (3) 0 1 (1)
Deemed Ineligible after Enrollment (due QTc> 450 ms) (%) 1 (3) 0 1 (1)